ArticleNature medicine2022
Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.
Open access · hybridAbstract readPublished Erratum
In one paragraph
Article in Nature medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
40 authors at 8 institutions in 4 countries.
A Magnani *Department of Biotherapy, Hôpital Universitaire Necker-Enfants Malades, Groupe Hospitalier Paris Centre, Assistance Publique-Hôpitaux de Paris, Paris, France.
M Semeraro *Clinical Investigation Center CIC 1419, Hôpital Universitaire Necker-Enfants Malades, Groupe Hospitalier Paris Centre, Université de Paris, Assistance Publique-Hôpitaux de Paris, Paris, France.
F AdamINSERM, UMR_S1176, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID http://orcid.org/0000-0001-6603-2687
C BoothDepartment of Paediatric Immunology, Great Ormond Street Hospital, London, UK.
L DupréToulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM, CNRS, Toulouse III Paul Sabatier University, Toulouse, France.
E C MorrisInstitute of Immunity and Transplantation, University College London, London, UK.ORCID http://orcid.org/0000-0003-4834-1130
A GabrionDepartment of Biotherapy, Hôpital Universitaire Necker-Enfants Malades, Groupe Hospitalier Paris Centre, Assistance Publique-Hôpitaux de Paris, Paris, France.
C RoudautDepartment of Biotherapy, Hôpital Universitaire Necker-Enfants Malades, Groupe Hospitalier Paris Centre, Assistance Publique-Hôpitaux de Paris, Paris, France.
D BorgelINSERM, UMR_S1176, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
A ToubertEMiLy, INSERM U1160, Institut de Recherche Saint Louis, Université de Paris, Paris, France.ORCID http://orcid.org/0000-0002-7308-7317
E ClaveEMiLy, INSERM U1160, Institut de Recherche Saint Louis, Université de Paris, Paris, France.ORCID http://orcid.org/0000-0001-8217-5039
C AbdoInstitut Necker-Enfants Malades (INEM), INSERM U1151, Université Paris Descartes Sorbonne Cité, Paris, France.
G GorochovDépartement d'Immunologie, Groupement Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
R PetermannPlatelet Immunology Department, INTS, Paris, France.
M GuiotDepartment of Biotherapy, Hôpital Universitaire Necker-Enfants Malades, Groupe Hospitalier Paris Centre, Assistance Publique-Hôpitaux de Paris, Paris, France.
M MiyaraDépartement d'Immunologie, Groupement Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
D MoshousDepartment of Pediatric Immunology, Hematology and Rheumatology, Assistance Publique-Hôpitaux de Paris, Necker-Enfants Malades University Hospital, Paris, France.
E MagrinDepartment of Biotherapy, Hôpital Universitaire Necker-Enfants Malades, Groupe Hospitalier Paris Centre, Assistance Publique-Hôpitaux de Paris, Paris, France.
A DenisHuman Lymphohematopoiesis Laboratory, Imagine Institute, INSERM UMR 1163, Université de Paris, Paris, France.
F SuarezImagine Institute, Université Paris Centre, Paris, France.
C LagresleHuman Lymphohematopoiesis Laboratory, Imagine Institute, INSERM UMR 1163, Université de Paris, Paris, France.ORCID http://orcid.org/0000-0002-2216-6453
A M RocheDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
J EverettDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
A TrinquandInstitut Necker-Enfants Malades (INEM), INSERM U1151, Université Paris Descartes Sorbonne Cité, Paris, France.
M GuissetToulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM, CNRS, Toulouse III Paul Sabatier University, Toulouse, France.
J Xu BayfordDepartment of Paediatric Immunology, Great Ormond Street Hospital, London, UK.
S Hacein-Bey-AbinaUnité des Technologies Chimiques et Biologiques pour la Santé, CNRS, INSERM, Université de Paris, Paris, France.
A KauskotINSERM, UMR_S1176, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID http://orcid.org/0000-0002-4064-8114
R ElfekyDepartment of Paediatric Immunology, Great Ormond Street Hospital, London, UK.
C RivatDepartment of Paediatric Immunology, Great Ormond Street Hospital, London, UK.
S AbbasGénéthon, Evry, France.
H B GasparDepartment of Paediatric Immunology, Great Ormond Street Hospital, London, UK.
E MacintyreInstitut Necker-Enfants Malades (INEM), INSERM U1151, Université Paris Descartes Sorbonne Cité, Paris, France.ORCID http://orcid.org/0000-0003-0520-0493
C PicardImagine Institute, Université Paris Centre, Paris, France.
F D BushmanDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-4740-4056
A GalyGénéthon, Evry, France.
A Fischer *Department of Pediatric Immunology, Hematology and Rheumatology, Assistance Publique-Hôpitaux de Paris, Necker-Enfants Malades University Hospital, Paris, France.ORCID http://orcid.org/0000-0003-4025-5983
E Six *Human Lymphohematopoiesis Laboratory, Imagine Institute, INSERM UMR 1163, Université de Paris, Paris, France.ORCID http://orcid.org/0000-0001-7806-0968
A J Thrasher *Department of Paediatric Immunology, Great Ormond Street Hospital, London, UK. a.thrasher@ucl.ac.uk.ORCID http://orcid.org/0000-0002-6097-6115
M Cavazzana *Department of Biotherapy, Hôpital Universitaire Necker-Enfants Malades, Groupe Hospitalier Paris Centre, Assistance Publique-Hôpitaux de Paris, Paris, France. m.cavazzana@aphp.fr.ORCID http://orcid.org/0000-0002-0264-0891
Hôpital Necker-Enfants Malades · FRInserm · FRGreat Ormond Street Hospital · GBCentre National de la Recherche Scientifique · FRUniversity of Pennsylvania · USUniversity of London Institute in Paris · FRGenethon (France) · FRRoyal Free London NHS Foundation Trust · GB
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.